
CAS 1413431-07-8
:Fórmula:C24H28N2O3
InChI:InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)/i4D3,5D3,6D3
Clave InChI:PURKAOJPTOLRMP-ASMGOKTBSA-N
SMILES:[2H]C([2H])([2H])C(C1=C(C=C(C(=C1)C(C)(C)C)NC(=O)C2=CNC3=CC=CC=C3C2=O)O)(C([2H])([2H])[2H])C([2H])([2H])[2H]
Filtrar por
Porcentaje de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Se han encontrado 6 productos.
- Precio más bajo
- Precio más alto
- Pureza más baja
- Pureza más alta
- Entrega estimada más rápida
N-(2-(tert-Butyl)-5-hydroxy-4-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
CAS:N-(2-(tert-Butyl)-5-hydroxy-4-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamideFórmula:C24H19D9N2O3Pureza:99.83%Peso molecular:401.55Ivacaftor (4-tertbutyl-d9) (Major)
CAS:Producto controladoFórmula:C24H19D9N2O3Forma y color:NeatPeso molecular:401.55Ivacaftor (4-tertbutyl-d9) (major)
CAS:Ivacaftor is a drug substance with the molecular formula C17H20Cl2O3, a monocarboxylic acid amide. Ivacaftor is indicated as a treatment for cystic fibrosis (CF) in patients age 12 years and older who have one of the following mutations: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or R117C. Ivacaftor binds to and activates the CFTR protein by increasing its stability and function. The carboxyl terminal domain of CFTR is required for interaction with ivacaftor. Ivacaftor also potentiates the activity of chromenes such as ivacaftor (4-tertbutyl-d9) and other cftr potentiators such as VX-770. These compounds are being studied in cancer treatment because they may be able toFórmula:C24H28N2O3Pureza:Min. 95%Peso molecular:401.5 g/molIvacaftor-D9
CAS:Ivacaftor-D9 is a deuterated compound of ivacaftor used for isotope tracing. Ivacaftor is an effective, orally administered CFTR modulator, cystic fibrosis.Fórmula:C24H19D9N2O3Pureza:99.13%Forma y color:White SolidPeso molecular:401.55





